Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / SHS USD
-
Number of holders
-
497
-
Total 13F shares, excl. options
-
61.8M
-
Shares change
-
+2.03M
-
Total reported value, excl. options
-
$6.56B
-
Value change
-
+$176M
-
Put/Call ratio
-
0.14
-
Number of buys
-
241
-
Number of sells
-
-276
-
Price
-
$106.12
Significant Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q2 2025
616 filings reported holding JAZZ - Jazz Pharmaceuticals plc - SHS USD as of Q2 2025.
Jazz Pharmaceuticals plc - SHS USD (JAZZ) has 497 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 61.8M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (6.09M shares), BlackRock, Inc. (5.8M shares), LSV ASSET MANAGEMENT (2.55M shares), Capital World Investors (2.54M shares), DIMENSIONAL FUND ADVISORS LP (2.54M shares), STATE STREET CORP (1.94M shares), AMERIPRISE FINANCIAL INC (1.87M shares), JPMORGAN CHASE & CO (1.72M shares), EcoR1 Capital, LLC (1.71M shares), and FULLER & THALER ASSET MANAGEMENT, INC. (1.63M shares).
This table shows the top 497 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.